- Onyx Scientific grows API GMP synthesis contract chemistry services
Contract chemistry specialists, Onyx Scientific, manufacture high value intermediates and APIs to global GMP-compliant standards for both phase I and phase II clinical studies. Expert in development stage API production, their breath of contract chemistry services include: GMP synthesis and scale up, solid-form polymorph investigation, salt selection, custom synthesis, process development and lead optimization.
(Filed: Thu Apr 08 2010)
- Movianto further expands European logistics for DAIICHI SANKYO
Movianto, a logistics company specialised in pharmaceutical and healthcare, has expanded the services for DAIICHI SANKYO EUROPE to three additional countries: Austria, Spain and Great Britain. Furthermore the companies’ existing successful cooperation in France is to be continued. Alongside the storage and distribution of DAIICHI SANKYO’s products, Movianto will also be undertaking diverse specialised services along the supply chain in these countries.
(Filed: Tue Mar 30 2010)
- One-Touch™ Single-Use Fluid Path Assemblies Enhance Operational Flexibility
One-Touch™ Single-Use Fluid Path Assemblies Enhance Operational Flexibility
Meissner’s One-Touch™ single-use fluid path assemblies are designed for secure fluid transfer in critical biopharmaceutical processing applications. The assemblies reduce process risk while providing an enhanced level of convenience that maximizes flexibility in the deployment of singleuse systems, as well as conventional systems.
(Filed: Sat Feb 27 2010)
- Onyx Scientific launches polymorph screening, solid-state chemistry services for pharmaceutical outs
Onyx Scientifics’ state-of-the-art, solid-state laboraory and automated screening platform enables rapid and efficient optimization of the physical form of a new compound, particularly the polymorphic form, through polymorphic screening, which displays unique physicochemical properties that can affect bioavailability, manufacturability, stability and other performance characteristics of a pharmaceutical.
(Filed: Fri Feb 05 2010)
- Famous London eel is vanishing from the Thames | ZSL London Zoo
Eel populations in the River Thames have crashed to alarmingly low levels, conservationists have revealed.
Over the last five years scientists from the Zoological Society of London (ZSL) have recorded a 98 per cent drop in the number of European eels within the river.
(Filed: Thu Jan 21 2010)
- Novus Biologicals announces opening of European office
Novus Biologicals, an international supplier of antibodies, biological products and materials to various scientific sectors, is proud to announce the opening of their first European office in Cambridge, England.
(Filed: Sat Nov 07 2009)
- Extinction crisis continues apace – IUCN
Gland, Switzerland, 3 November, 2009 (IUCN) – The latest update of the IUCN Red List of Threatened Species™ shows that 17,291 species out of the 47,677 assessed species are threatened with extinction.
(Filed: Thu Nov 05 2009)
- Search Engine Optimisation for Biotech and Pharma
Algorythm Solutions is pleased to announce the launch of its novel marketing service tailored specifically for the Biotechnology, Pharmaceutical and Life Science Industries
(Filed: Wed Nov 04 2009)
- Exceptional Young Scientist wins Acclaimed Pauline Ashley Prize
The Deafness Research UK Pauline Ashley Prize 2010 has been awarded to Nick Leach, a PhD student at the University of Oxford, for his highly commended and ongoing research into how the hearing brain adapts to different sounds.
(Filed: Fri Oct 23 2009)
|
